127 related articles for article (PubMed ID: 36661372)
1. An Autoantibody Subset Can Be Used for SCLC Early Detection.
Cancer Discov; 2023 Mar; 13(3):526. PubMed ID: 36661372
[TBL] [Abstract][Full Text] [Related]
2. Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy.
Kazarian M; Laird-Offringa IA
Mol Cancer; 2011 Mar; 10():33. PubMed ID: 21450098
[TBL] [Abstract][Full Text] [Related]
3. Posttranslational modifications induce autoantibodies with risk prediction capability in patients with small cell lung cancer.
Lastwika KJ; Kunihiro A; Solan JL; Zhang Y; Taverne LR; Shelley D; Rho JH; Randolph TW; Li CI; Grogan EL; Massion PP; Fitzpatrick AL; MacPherson D; Houghton AM; Lampe PD
Sci Transl Med; 2023 Jan; 15(678):eadd8469. PubMed ID: 36630482
[TBL] [Abstract][Full Text] [Related]
4. Anti-HuC and -HuD autoantibodies are differential sero-diagnostic markers for small cell carcinoma from large cell neuroendocrine carcinoma of the lung.
Matsumoto T; Ryuge S; Kobayashi M; Kageyama T; Hattori M; Goshima N; Jiang SX; Saegusa M; Iyoda A; Satoh Y; Masuda N; Sato Y
Int J Oncol; 2012 Jun; 40(6):1957-62. PubMed ID: 22426972
[TBL] [Abstract][Full Text] [Related]
5. EarlyCDT-Lung: an immunobiomarker test as an aid to early detection of lung cancer.
Lam S; Boyle P; Healey GF; Maddison P; Peek L; Murray A; Chapman CJ; Allen J; Wood WC; Sewell HF; Robertson JF
Cancer Prev Res (Phila); 2011 Jul; 4(7):1126-34. PubMed ID: 21733826
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies in lung cancer: possibilities for early detection and subsequent cure.
Chapman CJ; Murray A; McElveen JE; Sahin U; Luxemburger U; Türeci O; Wiewrodt R; Barnes AC; Robertson JF
Thorax; 2008 Mar; 63(3):228-33. PubMed ID: 17932110
[TBL] [Abstract][Full Text] [Related]
7. Small-Cell Carcinoma of the Lung: What We Learned about It?
Righi L; Volante M; Papotti M
Acta Cytol; 2022; 66(4):257-268. PubMed ID: 34784591
[TBL] [Abstract][Full Text] [Related]
8. NOL4 is a novel nuclear marker of small cell carcinoma and other neuroendocrine neoplasms.
Lee JH; Shin DH; Lee SY; Park JY; Kim SY; Hwang CS; Lee HJ; Na JY; Kim JY
Histol Histopathol; 2022 Nov; 37(11):1091-1098. PubMed ID: 36282054
[TBL] [Abstract][Full Text] [Related]
9. Immunobiomarkers in small cell lung cancer: potential early cancer signals.
Chapman CJ; Thorpe AJ; Murray A; Parsy-Kowalska CB; Allen J; Stafford KM; Chauhan AS; Kite TA; Maddison P; Robertson JF
Clin Cancer Res; 2011 Mar; 17(6):1474-80. PubMed ID: 21138858
[TBL] [Abstract][Full Text] [Related]
10. Paraneoplastic antigen Ma2 autoantibodies as specific blood biomarkers for detection of early recurrence of small intestine neuroendocrine tumors.
Cui T; Hurtig M; Elgue G; Li SC; Veronesi G; Essaghir A; Demoulin JB; Pelosi G; Alimohammadi M; Öberg K; Giandomenico V
PLoS One; 2010 Dec; 5(12):e16010. PubMed ID: 21209860
[TBL] [Abstract][Full Text] [Related]
11. Identification of Small and Non-Small Cell Lung Cancer Markers in Peripheral Blood Using Cytokinesis-Blocked Micronucleus and Spectral Karyotyping Assays.
El-Zein RA; Abdel-Rahman S; Santee KJ; Yu R; Shete S
Cytogenet Genome Res; 2017; 152(3):122-131. PubMed ID: 28898877
[TBL] [Abstract][Full Text] [Related]
12. Autoimmunity to SOX2, clinical phenotype and survival in patients with small-cell lung cancer.
Maddison P; Thorpe A; Silcocks P; Robertson JF; Chapman CJ
Lung Cancer; 2010 Dec; 70(3):335-9. PubMed ID: 20371131
[TBL] [Abstract][Full Text] [Related]
13. Application of serum NY-ESO-1 antibody assay for early SCLC diagnosis.
Yang J; Jiao S; Kang J; Li R; Zhang G
Int J Clin Exp Pathol; 2015; 8(11):14959-64. PubMed ID: 26823828
[TBL] [Abstract][Full Text] [Related]
14. Neuronal antibody detection and improved lung cancer prediction in Lambert-Eaton myasthenic syndrome.
Maddison P; Gozzard P; Sadalage G; Ambrose PA; Chapman CJ; Murray A; Thomsen S; Berretta A; Lang B
J Neuroimmunol; 2020 Mar; 340():577149. PubMed ID: 31951874
[TBL] [Abstract][Full Text] [Related]
15. The utility of anti-SOX2 antibodies for cancer prediction in patients with paraneoplastic neurological disorders.
Maddison P; Titulaer MJ; Verschuuren JJ; Gozzard P; Lang B; Irani SR; Sabater L; Graus F; Murray A; Chapman CJ
J Neuroimmunol; 2019 Jan; 326():14-18. PubMed ID: 30445363
[TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic acquired haemophilia A in extensive-stage small cell lung cancer (ES-SCLC) in the era of immunotherapy.
Pauls M; Rydz N; Nixon NA; Ezeife D
BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33509862
[TBL] [Abstract][Full Text] [Related]
17. Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer.
Massion PP; Healey GF; Peek LJ; Fredericks L; Sewell HF; Murray A; Robertson JF
J Thorac Oncol; 2017 Mar; 12(3):578-584. PubMed ID: 27615397
[TBL] [Abstract][Full Text] [Related]
18. Microtubule-associated protein 1B: Novel paraneoplastic biomarker.
Gadoth A; Kryzer TJ; Fryer J; McKeon A; Lennon VA; Pittock SJ
Ann Neurol; 2017 Feb; 81(2):266-277. PubMed ID: 28074593
[TBL] [Abstract][Full Text] [Related]
19. Analysis of unexpected small cell lung cancer following surgery as the primary treatment.
Yang H; Xu J; Yao F; Liang S; Zhao H
J Cancer Res Clin Oncol; 2018 Dec; 144(12):2441-2447. PubMed ID: 30341687
[TBL] [Abstract][Full Text] [Related]
20. Management of Small Cell Lung Cancer: Progress and Updates.
Altan M; Chiang AC
Cancer J; 2015; 21(5):425-33. PubMed ID: 26389768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
